Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability
Authors
Keywords
Warburg effect, Glucose metabolism, Lymphoma, <sup>18</sup>F-fluoro-2-deoxy-<span class=EmphasisTypeSmallCaps >d, 2-deoxy-<span class=EmphasisTypeSmallCaps >d
Journal
Journal of Translational Medicine
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-07-19
DOI
10.1186/s12967-017-1258-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations
- (2016) A. Louissaint et al. BLOOD
- mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells
- (2016) Raju V. Pusapati et al. CANCER CELL
- P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma
- (2015) Gabriel G. Vega et al. BMC CANCER
- The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism
- (2015) Jianrong Lu et al. CANCER LETTERS
- Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma
- (2015) Hideki Makinoshima et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The anti-tumor efficacy of 2-deoxyglucose and D-allose are enhanced with p38 inhibition in pancreatic and ovarian cell lines
- (2015) Scott W Malm et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Rapamycin Suppresses Tumor Growth and Alters the Metabolic Phenotype in T-Cell Lymphoma
- (2015) Wasakorn Kittipongdaja et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
- (2015) Jenny E Hernandez-Davies et al. Journal of Translational Medicine
- MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
- (2015) Toril Holien et al. Oncotarget
- Energy restriction mimetic agents to target cancer cells: Comparison between 2-deoxyglucose and thiazolidinediones
- (2014) Sandra Kuntz et al. BIOCHEMICAL PHARMACOLOGY
- Targeting PI3-kinase (PI3K), AKT and mTOR axis in lymphoma
- (2014) James S. Blachly et al. BRITISH JOURNAL OF HAEMATOLOGY
- Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma
- (2014) Jason R. Westin Clinical Lymphoma Myeloma & Leukemia
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- (2014) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells
- (2014) Jiandong Wang et al. Journal of Translational Medicine
- MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer
- (2014) Ayesha N Shajahan-Haq et al. Molecular Cancer
- AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake
- (2014) Ramachandran Rashmi et al. PLoS One
- HypoxamiRs and Cancer: From Biology to Targeted Therapy
- (2013) Harriet E. Gee et al. ANTIOXIDANTS & REDOX SIGNALING
- Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification
- (2013) G. Ott et al. BLOOD
- MEK1/2 Inhibition Decreases Lactate in BRAF-Driven Human Cancer Cells
- (2013) Maria Falck Miniotis et al. CANCER RESEARCH
- Non-Hodgkin’s B-cell lymphoma: Advances in molecular strategies targeting drug resistance
- (2013) Steve A Maxwell et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Proliferation Enhanced By NGF-NTRK1 Signaling Makes Pancreatic Cancer Cells More Sensitive To 2DG-Induced Apoptosis
- (2013) Yao Cheng et al. International Journal of Medical Sciences
- miRNAs link metabolic reprogramming to oncogenesis
- (2013) Maria Hatziapostolou et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- Roles of microRNA on cancer cell metabolism
- (2012) Bing Chen et al. Journal of Translational Medicine
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
- (2011) Dai Chihara et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Altered Subcellular Localization of c-Myc Protein Identifies Aggressive B-cell Lymphomas Harboring a c-MYC Translocation
- (2010) Marianna B. Ruzinova et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Mechanisms and functions of p38 MAPK signalling
- (2010) Ana Cuadrado et al. BIOCHEMICAL JOURNAL
- Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium
- (2010) Sonali M. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
- (2010) T E Witzig et al. LEUKEMIA
- Improved microRNA quantification in total RNA from clinical samples
- (2010) Ditte Andreasen et al. METHODS
- The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
- (2010) A. J. Levine et al. SCIENCE
- PET-CT in Radiation Oncology
- (2009) Dwight E. Heron et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Targeting the PI3K signaling pathway in cancer
- (2009) Kwok-Kin Wong et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Akt and c-Myc Differentially Activate Cellular Metabolic Programs and Prime Cells to Bioenergetic Inhibition
- (2009) Yongjun Fan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer
- (2008) Pamela A Davoren et al. BMC MOLECULAR BIOLOGY
- 2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer
- (2008) S L C Tagg et al. BRITISH JOURNAL OF CANCER
- Tumor Cell Metabolism: Cancer's Achilles' Heel
- (2008) Guido Kroemer et al. CANCER CELL
- Cancer Cell Metabolism: Warburg and Beyond
- (2008) Peggy P. Hsu et al. CELL
- Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
- (2008) J LOPICCOLO et al. DRUG RESISTANCE UPDATES
- MYCtranslocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation
- (2008) E Leucci et al. JOURNAL OF PATHOLOGY
- Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-d-glucose under hypoxia in lung cancer cell lines
- (2008) Medhi Wangpaichitr et al. MOLECULAR CANCER THERAPEUTICS
- Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis
- (2008) R. Brooks Robey et al. SEMINARS IN CANCER BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now